Scott Boyd, MD PhD

Pathologist, Hematopathologist

Stanford Hospital

Professional Education

  • Board Certification: Clinical Pathology, American Board of Pathology (2009)
  • Board Certification: Hematopathology, American Board of Pathology (2009)
  • Medical Education: Harvard Medical School (2005) MA
  • Ph.D., M.I.T., Biology (2004)
  • Residency: Stanford University School of Medicine (2007) CA
  • Fellowship: Stanford University School of Medicine (2008) CA
  • B.Sc.(Hons), University of Manitoba, Biochemistry (1992)
  • B.A., University of Oxford, English Literature (1994)

Honors & Awards

  • Frank Knox Fellowship, Harvard University (1994)
  • Governor General Medal, highest undergraduate standing, University of Manitoba (1992)
  • Harry B. Neustein Award, Society of Pediatric Pathology (2008)
  • Neurofibromatosis (NF) Foundation, 1st Prize, Neurofibromatosis Foundation (2002)
  • New Scholar Award in Aging, Ellison Medical Foundation (2011)
  • Postdoctoral Fellow Mentor Award, Department of Immunology, Stanford University (2017)
  • Pre-doctoral fellowship, Howard Hughes Medical Institutes (1997)
  • Rhodes Scholarship, University of Oxford (1992-4)
  • Thomas Jefferson Award, St. Catherine's College, Oxford (1994)
  • University Gold Medal, highest standing in honors science, University of Manitoba (1992)
  • Walter V. and Idun Berry Fellowship, Stanford University (2008)
  • Young Investigator Award, Society of Pediatric Pathology (2007)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.